市場調查報告書

全球醫生處方的功能性化妝品市場:成長,趨勢,及預測

Physician Dispensed Cosmeceuticals Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922049
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
全球醫生處方的功能性化妝品市場:成長,趨勢,及預測 Physician Dispensed Cosmeceuticals Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 113 Pages
簡介

本報告提供全球醫生處方的功能性化妝品市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各類型·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 審美意識的高漲
    • 醫生處方化妝品相關認識的高漲
  • 市場阻礙因素
    • 產品的高成本
    • 缺乏專業訓練的專家
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 護膚
    • 眼睛保健品
    • 護髮
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Allergan
    • Merz Pharma
    • INNOVATIVE SKINCARE
    • Obagi Cosmeceuticals LLC
    • SkinCeuticals International
    • JMSR, Inc.
    • CUSKIN.
    • Khiron Life Sciences Corp
    • La Roche-Posay

第7章 市場機會及今後趨勢

目錄
Product Code: 67583

Market Overview

Physician Dispensed Cosmeceuticals are the custom made products that penetrate deeper into the skin than the normal OTC products. As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market. Most Physician lines are designed and formulated by the physicians, skin professionals and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, increasing importance on the beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market. Moreover, several local dermatologists owned professional startups specializing in the cosmeceuticals have rapidly entered into the market which is catering to the growth of the market by driving the demand for the usage of physician-dispensed cosmeceuticals among localities.

Scope of the Report

Physician Dispensed Cosmeceuticals refers to products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. Many physicians whose practices or specialties involve skin health, choose to dispense these cosmeceuticals or have them specially compounded, to offer heightened results to their patients and to enhance their results with other treatments. Physician-Dispensed skincare is not officially recognized by the FDA.

Key Market Trends

Anti-aging segment holds a significant market share

  • Consumers, especially the aging population, are increasingly looking for methods and products to maintain and improve their appearance to look youthful and beautiful, more so with the rising awareness about anti-aging products.
  • The middle-aged people are increasingly witnessing aging anxiety, due to the high prevalence of extrinsic signs of aging.
  • Anti-aging skin products are known as cosmeceuticals, as they overlap the distinction between cosmetics and pharmaceuticals.
  • Obagi Nu-Derm System from Obagi Cosmeceuticals LLC is a Wide-ranging skincare product especially formulated for normal to dry skin to help to correct hyperpigmentation and transform the appearance of aging skin.

The Asia Pacific is the fastest-growing region in Global Physician Dispensed Cosmeceuticals Market

The market in the Asia Pacific region is expected to grow significantly over the forecast period. Growing preference to behold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific. the population of Japan is among the most prolific consumers of cosmetics, placing it among the top five national markets for personal care products.

Competitive Landscape

The market is moderately competitive due to the presence of many small and large manufacturers. competition in the market is high due to the increasing investments in R&D for product innovation and increasing efficiency of the product by launching new products into the market. Key market players in the respective market are Allergan, Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International amongst others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Beauty Consciousness
    • 4.2.2 Growing Awareness About Physician Dispensed Cosmeceuticals
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Products
    • 4.3.2 Lack of Trained and Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Skin Care
      • 5.1.1.1 Anti-Ageing
      • 5.1.1.2 Sunscreens
      • 5.1.1.3 Other Skin Care Products
    • 5.1.2 Eye Care
      • 5.1.2.1 Prescription Drops
      • 5.1.2.2 Artificial Tears
      • 5.1.2.3 Other Eye Care Products
    • 5.1.3 Hair Care
      • 5.1.3.1 Hair Repair
      • 5.1.3.2 Anti-dandruff
      • 5.1.3.3 Other Hair care Products
    • 5.1.4 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan
    • 6.1.2 Merz Pharma
    • 6.1.3 INNOVATIVE SKINCARE
    • 6.1.4 Obagi Cosmeceuticals LLC
    • 6.1.5 SkinCeuticals International
    • 6.1.6 JMSR, Inc.
    • 6.1.7 CUSKIN.
    • 6.1.8 Khiron Life Sciences Corp
    • 6.1.9 La Roche-Posay

7 MARKET OPPORTUNITIES AND FUTURE TRENDS